Regencell Bioscience Holdings Ltd (RGC)
6.30
+0.20
(+3.28%)
USD |
NASDAQ |
Nov 15, 16:00
6.30
0.00 (0.00%)
After-Hours: 16:38
Regencell Bioscience Holdings Total Assets (Quarterly): 8.438M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 8.438M |
| December 31, 2023 | 10.48M |
| December 31, 2023 | 10.48M |
| June 30, 2023 | 12.62M |
| December 31, 2022 | 15.55M |
| December 31, 2022 | 15.55M |
| June 30, 2022 | 18.02M |
| Date | Value |
|---|---|
| December 31, 2021 | 21.06M |
| December 31, 2021 | 21.06M |
| June 30, 2021 | 0.3401M |
| December 31, 2020 | 0.6004M |
| December 31, 2020 | 0.6004M |
| June 30, 2020 | 0.514M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.3401M
Minimum
Jun 2021
21.06M
Maximum
Dec 2021
10.41M
Average
10.48M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| Sino Biopharmaceutical Ltd | 9.177B |
| HUTCHMED (China) Ltd | 1.261B |
| Pharmaron Beijing Co Ltd | 3.058B |
| Prenetics Global Ltd | 233.31M |
| Uni-Bio Science Group Ltd | 62.37M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.2195M |
| Shareholders Equity (Quarterly) | 8.219M |